Statistics
Publications
26
Citations
3.1K
H-Index
21
Active since
2003
Mitsunori Kato is an author at Novartis (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.
Publications per year
2003–2024
26
26
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations
Small-molecule WNK inhibition regulates cardiovascular and renal function
Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 167 citations · Full text
1–5 of 26